Filing Details

Accession Number:
0001628280-24-050113
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-12-05 17:05:14
Reporting Period:
2024-11-01
Accepted Time:
2024-12-05 17:05:14
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1087294 Cumberland Pharmaceuticals Inc CPIX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1684087 Caroline Young 1600 West End Avenue
Suite 1300
Nashville TN 37203
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-11-01 38 $1.15 29,055 No 5 P Direct
Common Stock Acquisiton 2024-11-04 25 $1.17 29,080 No 5 P Direct
Common Stock Acquisiton 2024-11-05 38 $1.20 29,118 No 5 P Direct
Common Stock Acquisiton 2024-11-06 38 $1.20 29,156 No 5 P Direct
Common Stock Acquisiton 2024-11-07 38 $1.17 29,194 No 5 P Direct
Common Stock Acquisiton 2024-11-08 38 $1.18 29,232 No 5 P Direct
Common Stock Acquisiton 2024-11-11 38 $1.20 29,270 No 5 P Direct
Common Stock Acquisiton 2024-11-12 38 $1.20 29,308 No 5 P Direct
Common Stock Acquisiton 2024-11-13 38 $1.20 29,346 No 5 P Direct
Common Stock Acquisiton 2024-11-14 38 $1.19 29,384 No 5 P Direct
Common Stock Acquisiton 2024-11-15 38 $1.17 29,422 No 5 P Direct
Common Stock Acquisiton 2024-11-18 38 $1.18 29,460 No 5 P Direct
Common Stock Acquisiton 2024-11-19 38 $1.15 29,498 No 5 P Direct
Common Stock Acquisiton 2024-11-20 43 $1.13 29,541 No 5 P Direct
Common Stock Acquisiton 2024-11-21 43 $1.09 29,584 No 5 P Direct
Common Stock Acquisiton 2024-11-22 16 $1.07 29,600 No 5 P Direct
Common Stock Acquisiton 2024-11-25 16 $1.09 29,616 No 5 P Direct
Common Stock Acquisiton 2024-11-26 16 $1.09 29,632 No 5 P Direct
Common Stock Acquisiton 2024-11-27 16 $1.15 29,648 No 5 P Direct
Common Stock Acquisiton 2024-11-29 16 $1.32 29,664 No 5 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 5 P Direct
No 5 P Direct
No 5 P Direct
No 5 P Direct
No 5 P Direct
No 5 P Direct
No 5 P Direct
No 5 P Direct
No 5 P Direct
No 5 P Direct
No 5 P Direct
No 5 P Direct
No 5 P Direct
No 5 P Direct
No 5 P Direct
No 5 P Direct
No 5 P Direct
No 5 P Direct
No 5 P Direct
No 5 P Direct
Footnotes
  1. The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024.